RECRUITING Not applicable ClinicalTrials.gov

The Effects of Carnitine Supplementation on Oocytes in Women Undergoing IVF Process

Sponsor: The Obstetrics and Gynaecology Clinic Narodni Front • ClinicalTrials.gov ID: NCT07783399

Registry updated: 2026-10-16

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The goal of this clinical trial is to learn whether supplementation with L-carnitine improves outcomes in women undergoing in vitro fertilization (IVF). It will also evaluate the effect of supplementation on oocyte quality, embryo quality, and pregnancy rates. The main questions it aims to answer are: * Does supplementation improve the number and quality of oocytes retrieved during IVF treatment? * Does supplementation improve the number and quality of embryos obtained after fertilization? * Does supplementation increase the rates of biochemical and clinical pregnancy? Researchers will compare women receiving supplementation with women not receiving supplementation to determine whether the supplements improve IVF outcomes.

Interventions

L-Carnitine Group (Dietary supplement)
A supplementation group will receive L-carnitine (500 mg) daily for 12 weeks before oocyte retrieval.

Eligibility criteria

Inclusion Criteria: * women undergoing IVF process * women aged 18-45 years Exclusion Criteria: * obesity * severe kidney disease * liver insufficiency * endocrine disorders * the use of immunosuppressive medications

Conditions

Infertility (IVF Patients)

Locations

Clinic for Gynecology and Obstetrics Narodni Front — Belgrade, Savski Venac, Serbia

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment